Inventor · disambiguated record
Theodore Yednock
Also filed as: YEDNOCK THEODORE · YEDNOCK THEODORE A
25 granted patents·25 pending applications·622 citations·filing 1995–2022
97Inventor score
Top patents by PatentIndex Score
50 records- 0198US6750324B1Humanized and chimeric N-terminal amyloid beta-antibodiesNEURALAB LTD·Filed 2000·Granted Jun 15, 2004·202 cites·12 claims
- 0295US9447190B2Anti-MCAM antibodies and associated methods of useNEOTOPE BIOSCIENCES LTD·Filed 2013·Granted Sep 20, 2016·32 cites·22 claims
- 0395US7807167B2Administration of agents for the treatment of inflammationELAN PHARM INC·Filed 2006·Granted Oct 5, 2010·37 cites·11 claims
- 0495US7575880B1Method of screening an antibody for activity in clearing an amyloid depositELAN PHARMA INT LTD·Filed 2000·Granted Aug 18, 2009·42 cites·4 claims
- 0595US6033665ACompositions and methods for modulating leukocyte adhesion to brain endothelial cellsELAN PHARM INC·Filed 1995·Granted Mar 7, 2000·141 cites·13 claims
- 0694US10414825B2Anti-MCAM antibodies and associated methods of usePROTHENA BIOSCIENCES LTD·Filed 2016·Granted Sep 17, 2019·14 cites·25 claims
- 0791US8034348B2Prevention and treatment of amyloidogenic diseaseJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2007·Granted Oct 11, 2011·9 cites·20 claims
- 0890US10584177B2Anti-MCAM antibodies and associated methods of usePROTHENA BIOSCIENCES LTD·Filed 2017·Granted Mar 10, 2020·6 cites·8 claims
- 0989US10407507B2Anti-MCAM antibodies and associated methods of usePROTHENA BIOSCIENCES LTD·Filed 2016·Granted Sep 10, 2019·6 cites·9 claims
- 1089US10059761B2Anti-Laminin4 antibodies specific for LG4-5PROTHENA BIOSCIENCES LTD·Filed 2015·Granted Aug 28, 2018·8 cites·37 claims
- 1187US6664442B2Selecting compounds to reduce inflammation associated with Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted Dec 16, 2003·29 cites·43 claims
- 1286US8642044B2Prevention and treatment of amyloidogenic diseaseSCHENK DALE B·Filed 2007·Granted Feb 4, 2014·4 cites·28 claims
- 1380US7517525B2Methods of inhibiting amyloid toxicityELAN PHARM INC·Filed 2002·Granted Apr 14, 2009·18 cites·23 claims
- 1480US6001809AInhibitors of leukocyte adhesionELAN PHARM INC·Filed 1995·Granted Dec 14, 1999·33 cites·13 claims
- 1579US10654920B2Anti-laminin4 antibodies specific for LG4-5PROTHENA BIOSCIENCES LTD·Filed 2018·Granted May 19, 2020·1 cites·10 claims
- 1679US7901683B2Methods of inhibiting amyloid toxicityELAN PHARM INC·Filed 2008·Granted Mar 8, 2011·3 cites·21 claims
- 1778US2022162321A1Administration of agents for the treatment of inflammationBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 1873US11248051B2Administration of agents for the treatment of inflammationBIOGEN MA INC·Filed 2019·Granted Feb 15, 2022·0 cites·7 claims
- 1972US5811514AIntegrin blocking moleculeATHENA NEUROSCIENCES·Filed 1995·Granted Sep 22, 1998·22 cites·7 claims
- 2071US11333670B2Methods of treating inflammatory and autoimmune diseases with natalizumabBIOGEN MA INC·Filed 2019·Granted May 17, 2022·0 cites·12 claims
- 2170US2020216560A1Anti-MCAM Antibodies And Associated Methods Of UsePROTHENA BIOSCIENCES LTD·Filed 2020·Application pending·0 cites
- 2268US2004247590A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 2368US2005158304A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 2467US10889636B2Anti-Laminin4 antibodies specific for LG4-5PROTHENA BIOSCIENCES LTD·Filed 2018·Granted Jan 12, 2021·0 cites·9 claims
- 2567US7605166B2Methods and compositions for treating rheumatoid arthritisELAN PHARM INC·Filed 2004·Granted Oct 20, 2009·3 cites·19 claims
- 2667US2004247591A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 2767US2004265301A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 2867US2006121038A9Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 2966US10466251B2Methods of treating inflammatory and autoimmune diseases with natalizumabYEDNOCK THEODORE A·Filed 2012·Granted Nov 5, 2019·1 cites·18 claims
- 3063US2013058869A1Prevention And Treatment Of Amyloidogenic DiseaseSCHENK DALE B·Filed 2011·Application pending·0 cites
- 3162US2005142132A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2005·Application pending·0 cites
- 3262US2017306026A1Administration of agents for the treatment of inflammationBIOGEN IDEC INC·Filed 2017·Application pending·0 cites
- 3359US2013338164A1Multimeric VLA-4 Antagonists Comprising Polymers MoietiesELAN PHARM INC·Filed 2013·Application pending·0 cites
- 3458US2012329807A1Multimeric VLA-4 Antagonists Comprising Polymers MoietiesKONRADI ANDREI·Filed 2012·Application pending·0 cites
- 3557US7794700B2Multimeric VLA-4 antagonists comprising polymer moietiesELAN PHARM INC·Filed 2005·Granted Sep 14, 2010·0 cites·30 claims
- 3655US2015152182A1Administration of agents for the treatment of inflammationBIOGEN IDEC INC·Filed 2015·Application pending·0 cites
- 3755US2011064729A1Administration of agents for the treatment of inflammationELAN PHARM INC·Filed 2010·Application pending·0 cites
- 3855US2006029600A1Treatment of viral encephalitis by agents blocking alpha-VLA-4 integrin functionATHENA NEUROSCIENCES JOHNS HOP·Filed 2004·Application pending·0 cites
- 3954US2004009169A1Administration of agents for the treatment of inflammationFiled 2003·Application pending·0 cites
- 4054US2005059802A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 4154US2005059591A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 4254US2020165336A1Mcam antagonists and methods of treatmentPROTHENA BIOSCIENCES LTD·Filed 2019·Application pending·0 cites
- 4352US8263063B2Multimeric VLA-4 antagonists comprising polymer moietiesKONRADI ANDREI W·Filed 2010·Granted Sep 11, 2012·0 cites·30 claims
- 4452US2007231319A1Methods of treating inflammatory and autoimmune diseases with natalizumabYEDNOCK THEODORE A·Filed 2007·Application pending·0 cites
- 4551US6939855B2Anti-inflammatory compositions and methodWYETH CORP·Filed 1998·Granted Sep 6, 2005·11 cites·8 claims
- 4647US2014314744A1Mcam antagonists and methods of treatmentFLANAGAN KENNETH·Filed 2012·Application pending·0 cites
- 4745US2005272668A1Anti-inflammatory compositions and methodsYEDNOCK THEODORE A·Filed 2005·Application pending·0 cites
- 4836US2012059029A1Selective integrin inhibitorsPEPIO ANTHONY·Filed 2011·Application pending·0 cites
- 4933US2017158755A1Anti-laminin4 antibodies specific for lg1-3PROTHENA BIOSCIENCES LTD·Filed 2015·Application pending·0 cites
- 5031US2017002077A1Combination treatment for multiple sclerosisPROTHENA BIOSCIENCES LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Theodore Yednock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →